RIFAMPICIN Labatec 300 mg i.v. flac
7680651010011
CH-65101
J04AB02
08.02.1.
1 / 3
google
Details
- Product number
- 6510101
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: rifampicinum 300 mg ut rifampicinum natricum, natrii ascorbas, pro vitro corresp. natrium 9 mg.
Articles (1)
Rifampicin Labatec i.v. 300mg, poudre pour solution pour perfusion
Puder
1
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | WIZUS |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
9.0 MG | Substance | HBESI |
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 65101
- Drug name
- Rifampicin Labatec i.v., poudre pour solution pour perfusion
- Galenic form
- PULVI
- ATC Code
- J04AB02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 28/05/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 08.02.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- RIFAMPICIN Labatec 300 mg i.v. flac
- Description (DE)
- RIFAMPICIN Labatec 300 mg i.v. Durchstf
- Market launch
- 28/05/2014
- Narcotic (BTM)
- No